A Pan-cancer Transcriptome Analysis Reveals Pervasive Regulation through Alternative Promoters.
Clicks: 266
ID: 40423
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
82.6
/100
266 views
213 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Most human protein-coding genes are regulated by multiple, distinct promoters, suggesting that the choice of promoter is as important as its level of transcriptional activity. However, while a global change in transcription is recognized as a defining feature of cancer, the contribution of alternative promoters still remains largely unexplored. Here, we infer active promoters using RNA-seq data from 18,468 cancer and normal samples, demonstrating that alternative promoters are a major contributor to context-specific regulation of transcription. We find that promoters are deregulated across tissues, cancer types, and patients, affecting known cancer genes and novel candidates. For genes with independently regulated promoters, we demonstrate that promoter activity provides a more accurate predictor of patient survival than gene expression. Our study suggests that a dynamic landscape of active promoters shapes the cancer transcriptome, opening new diagnostic avenues and opportunities to further explore the interplay of regulatory mechanisms with transcriptional aberrations in cancer.Reference Key |
demircioglu2019acell
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Demircioğlu, Deniz;Cukuroglu, Engin;Kindermans, Martin;Nandi, Tannistha;Calabrese, Claudia;Fonseca, Nuno A;Kahles, André;Lehmann, Kjong-Van;Stegle, Oliver;Brazma, Alvis;Brooks, Angela N;Rätsch, Gunnar;Tan, Patrick;Göke, Jonathan; |
Journal | Cell |
Year | 2019 |
DOI | S0092-8674(19)30906-7 |
URL | |
Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.